novo direct semaglutide asks FDA to bar compounders from making copies Novo Nordisk Launches Lower-Cost Wegovy,

Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through -5 studies (abstract)

Neurological deficit was assessed by the National Institutes of Health Stroke Scale (NIHSS) on the first day, functional outcome and independence were assessed by the modified Rankin scale (mRs) and Bartel index (BI), respectively, after 21 days

Moreover, since thyroid input represents only one potential mechanism of increased BAT and GWAT thermogenesis, we also examined potential alterations in the sympathetic nervous system (SNS) inputs

& Trotter, P

A recent randomised clinical trial demonstrated that exenatide, a GLP-1 receptor agonist, significantly reduced ICP in patients with active IIH from as early as 2.5 h, with effects seen at 24 h and 3 months with continued dosing